Physician profile
Sofia E Klar
NPI 1760944391
$2,066.88
in general payments reported to CMS, 2019-2025
19 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $182 · 2023: $195 · 2024: $509 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.97 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $439.10 | 2023-2025 | Injectafer |
| Astellas Pharma US INC | $412.74 | 2023-2025 | Veozah |
| Biogen, INC. | $232.16 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $206.10 | 2023-2025 | Myfembree, Gemtesa, Orgovyx |
| Hologic Sales and Service, LLC | $189.80 | 2024-2025 | Acessa Provu System, Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Minerva Surgical, INC | $146.00 | 2022 | |
| Mayne Pharma Commercial LLC | $107.96 | 2025 | |
| Evofem Biosciences, INC. | $59.94 | 2024-2025 | Solosec, Phexx, Phexxi |
| Smith+Nephew, INC. | $45.79 | 2023 | Pico 7 |
| Bayer Healthcare Pharmaceuticals INC. | $38.36 | 2024-2025 | |
| Convatec INC. | $27.91 | 2025 | |
| Coopersurgical, INC. | $24.83 | 2024 | Paragard T 380a |
| Organon LLC | $23.94 | 2024 | |
| Exeltis, USA INC. | $22.84 | 2025 | Slynd |
| Octapharma USA, INC. | $21.70 | 2025 | Fibryga |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.24 | 2022 | |
| Pfizer INC. | $16.54 | 2024 | |
| Incyte Corporation | $15.67 | 2022 | |
| Meditrina | $15.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Klar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.